Research - Page 143 of 720 Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Atrial fibrillation as a side effect of ibrutinib treatment in patients with chronic lymphocytic leukemia

Atrial fibrillation as a side effect of ibrutinib treatment in patients with chronic lymphocytic leukemia

Posted by on Jun 23, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the occurrence of atrial fibrillation (abnormal heart rhythm) in patients with chronic lymphocytic leukemia who are treated with ibrutinib.   This study concluded that atrial fibrillation does not require ibrutinib treatment to be stopped but is associated with worse outcomes for...

Read More

Cytarabine, aclarubicin and G-CSF as salvage treatment for hard to treat T cell acute lymphoblastic leukemia

Cytarabine, aclarubicin and G-CSF as salvage treatment for hard to treat T cell acute lymphoblastic leukemia

Posted by on Jun 23, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate cytarabine (Cytosar-U), aclarubicin (Aclacin) and G-CSF (Neupogen) as a salvage treatment for adult patients with relapsed or refractory T cell acute lymphoblastic leukemia.   This study concluded that this treatment combination is safe and effective as a salvage treatment...

Read More

What is the best treatment approach for patients newly diagnosed with multiple myeloma?

What is the best treatment approach for patients newly diagnosed with multiple myeloma?

Posted by on Jun 23, 2020 in Multiple Myeloma | 0 comments

In a nutshell This study investigated which was the best treatment approach before and after stem cell transplantation (SCT) for patients newly diagnosed with multiple myeloma (MM). The results showed that patients’ survival was better with CRD (cyclophosphamide, lenalidomide, and dexamethasone) chemotherapy than with CTD (cyclophosphamide,...

Read More

Can an intensive lifestyle change reduce diabetes symptoms in patients with early type 2 diabetes?

Can an intensive lifestyle change reduce diabetes symptoms in patients with early type 2 diabetes?

Posted by on Jun 23, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined if an intensive diet and exercise plan could reduce blood glucose levels and body weight of patients with early type 2 diabetes (T2D). The results showed that an intensive lifestyle change significantly reduced the number of patients with T2D and patients’ body weight. Some background The high blood...

Read More

Are a combination of insulin injections and continuous pump better for patients with type 1 diabetes who partake in exercise?

Are a combination of insulin injections and continuous pump better for patients with type 1 diabetes who partake in exercise?

Posted by on Jun 23, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined which controlled blood glucose levels better in patients with type 1 diabetes (T1D) partaking in exercise – insulin pumps or a combination of insulin pumps and long-acting injections. The authors found that the combination was more effective for these patients. Some background Exercise has numerous...

Read More

Is an anti-clotting injection selatogrel effective for patients suffering from heart attacks?

Is an anti-clotting injection selatogrel effective for patients suffering from heart attacks?

Posted by on Jun 22, 2020 in Coronary artery disease | 0 comments

In a nutshell This study examined how fast and effective a dose of an anti-clotting injection, selatogrel, was for patients suffering from heart attacks. The authors found that both doses were effective by 30 minutes, but the high dose worked faster. Some background At the beginning of a heart attack, patients should be given anti-clotting...

Read More

Does enzalutmide improve survival in nonmetastatic, castration-resistant prostate cancer?

Does enzalutmide improve survival in nonmetastatic, castration-resistant prostate cancer?

Posted by on Jun 21, 2020 in Prostate cancer | 0 comments

In a nutshell The study assessed whether enzalutamide (Xtandi) plus androgen deprivation therapy (ADT) increased overall survival (OS) of patients with nonmetastatic, castration-resistant prostate cancer (CRPC). The study found improved survival in patients with CRPC treated with enzalutamide. Some background ADT is a type of hormonal therapy...

Read More

How does COVID-19 affect patients with cancer undergoing chemotherapy?

How does COVID-19 affect patients with cancer undergoing chemotherapy?

Posted by on Jun 21, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined how COVID-19 infection affects patients with cancer undergoing chemotherapy and the role of other factors in COVID-19 complications. The results showed that patients with advanced age and other medical conditions had a higher risk of COVID-19 complications but chemotherapy treatment did not need to be stopped. Some...

Read More

How does COVID-19 affect patients with cancer undergoing chemotherapy?

How does COVID-19 affect patients with cancer undergoing chemotherapy?

Posted by on Jun 21, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined how COVID-19 infection affects patients with cancer undergoing chemotherapy and the role of other factors in COVID-19 complications. The results showed that patients with advanced age and other medical conditions had a higher risk of COVID-19 complications but chemotherapy treatment did not need to be stopped. Some...

Read More